Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Chris Viehbacher
Pharma
Biogen's fortunes are trending upward thanks to its new launches
As Leqembi and Skyclarys launches gain steam, Biogen's CEO Chris Viehbacher admitted Wednesday that the company still has “a lot of work to do."
Fraiser Kansteiner
Apr 24, 2024 11:24am
Biogen CEO's 2023 pay shrank by 87%
Apr 16, 2024 1:00pm
Biogen CEO plots turnaround after 'weak' 2023 performance
Feb 13, 2024 11:28am
After 40% reduction in workforce, Sage will shift to smaller HQ
Jan 25, 2024 10:55am
Biogen kicks off 1,000 layoffs
Aug 18, 2023 10:43am
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys
Jul 28, 2023 11:17am
